US Stock MarketDetailed Quotes

TCRX TScan Therapeutics

Watchlist
  • 8.560
  • -0.090-1.04%
Close May 3 16:00 ET
  • 8.960
  • +0.400+4.67%
Pre 06:13 ET
431.23MMarket Cap-6294P/E (TTM)

TScan Therapeutics Key Stats

TScan Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

7.21M

+132.99%
EPS(YoY)

-0.11

+85.90%

Strong Buy

Apr 30, 2024

TScan Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 4.421M--
--2024/Q1-- / 4.300M--
--2023/Q47.211M / 3.454M--
--2023/Q33.887M / 4.451M--
--2023/Q23.148M / 4.374M--
--2023/Q16.803M / 4.304M--
--2022/Q43.096M / 4.098M--
--2022/Q33.363M / 3.930M--
--2022/Q24.056M / 3.004M--
--2022/Q13.021M / 2.755M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 4.421M--
--2024/Q1-- / 4.300M--
--2023/Q47.211M / 3.454M--
--2023/Q33.887M / 4.451M--
--2023/Q23.148M / 4.374M--
--2023/Q16.803M / 4.304M--
--2022/Q43.096M / 4.098M--
--2022/Q33.363M / 3.930M--
--2022/Q24.056M / 3.004M--
--2022/Q13.021M / 2.755M--

Unlock Free Earnings Estimates

TScan Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 30, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg